2. Academic Validation
  3. Covalent binding of 5-tetradecyloxy-2-furoic acid (TOFA) and c(RGDfK) and its co-delivery with Lipusu, a novel synergistic strategy to inhibit the proliferation of nasopharyngeal cancer

Covalent binding of 5-tetradecyloxy-2-furoic acid (TOFA) and c(RGDfK) and its co-delivery with Lipusu, a novel synergistic strategy to inhibit the proliferation of nasopharyngeal cancer

  • Eur J Pharm Sci. 2025 Jun 1:209:107092. doi: 10.1016/j.ejps.2025.107092.
Min Feng 1,  Wei Gong 1,  Xin Zhu 2,  Juan Zhu 3,  Junjie Hu 4,  Weihua Xu 5,  Zhichao Ma 4,  Shengmiao Fu 6,  Xinping Chen 7
Affiliations

Affiliations

  • 1 College of Life Sciences and Pharmacy, Hainan University, Haikou, Hainan, PR China; Department of Medical Laboratory, Hainan Cancer Hospital, Affiliated Cancer Hospital of Hainan Medical University, Haikou, Hainan, PR China.
  • 2 College of Life Sciences and Pharmacy, Hainan University, Haikou, Hainan, PR China.
  • 3 Department of Pathology, Yancheng City Dafeng People's Hospital, Yanchen, Jiangsu, PR China.
  • 4 Department of Medical Laboratory, Hainan Cancer Hospital, Affiliated Cancer Hospital of Hainan Medical University, Haikou, Hainan, PR China.
  • 5 Department of Medical Laboratory, Hainan Cancer Hospital, Affiliated Cancer Hospital of Hainan Medical University, Haikou, Hainan, PR China; Hainan Tropical Cancer Research Institute, Haikou, Hainan, PR China.
  • 6 Hainan Lvtou Medical Laboratory Center, Haikou, Hainan, PR China. Electronic address: fusm58@126.com.
  • 7 College of Life Sciences and Pharmacy, Hainan University, Haikou, Hainan, PR China; Department of Medical Laboratory, Hainan Cancer Hospital, Affiliated Cancer Hospital of Hainan Medical University, Haikou, Hainan, PR China; Hainan Tropical Cancer Research Institute, Haikou, Hainan, PR China. Electronic address: chenxinping52@126.com.
PMID: 40228725 DOI: 10.1016/j.ejps.2025.107092
Abstract

As the world's only commercially available paclitaxel Liposome, Lipusu (Lip) has been clinically used in chemotherapy for >20 years, but the design concept of Lip remains largely unchanged since its initial development. Based on the study of Acetyl-CoA-carboxylase 1 (ACC1) in nasopharyngeal carcinoma (NPC), we proposed the concept of next-generation liposomes (NGL) utilizing lipid demand balance. In this study, we evaluated the feasibility of ACC1 and Integrin αVβ3 as NPC targets, and designed 10 conjugates of 5-tetradecyloxy-2-furoic acid (TOFA) and c(RGDfK) that can bind to Lip. Considering the results of chemical parameter prediction, molecular docking, molecular dynamics simulation (MD) and Other aspects, we finally selected and synthesized the compound F, and successfully constructed F-Lip by simple incubation method. Compared with Lip, F-Lip showed stronger toxicity in both HONE-1 cells and corresponding tumor-bearing mice. In conclusion, by regulating the balance of lipid demand, the toxicity of Lip can be improved so as to achieve the goal of inhibiting the proliferation of NPC. This study provides a new model for the future design and development of Lip.

Keywords

Lipusu; Nasopharyngeal cancer; TOFA; c(RGDfK).

Figures
Products
嗨！很高兴为您提供帮助！

尊敬的 MCE 客户您好，
请您选择所在区域，我们将转接对应客服为您服务！

热门区域

A

B

C

F

G

H

J

L

N

Q

S

T

X

Y

Z

热 A B C F G H J L N Q S T X Y Z